Pre-Entry TB Screening: Indonesia Added
Japan begins pre-entry tuberculosis screening (JPETS) in Indonesia on Nov 2, 2026. From Jan 4, 2027, a TB-free certificate must be submitted with a Certificate of Eligibility or visa application.
Effective April 1, 2026 — Choosing brand-name means paying 1/4 of the price gap
The "selected medical treatment" system for long-listed drugs is expanding with 34 new additions, totaling 775 items. When patients choose a brand-name drug over a generic equivalent, they must pay an extra 25% (1/4) of the price difference out of pocket.
Brand-name: ¥200/tablet, Generic: ¥80/tablet. Difference ¥120 × 1/4 = ¥30 extra. At 30% copay: normal ¥60 + extra ¥30 = ¥90 total.
Japan begins pre-entry tuberculosis screening (JPETS) in Indonesia on Nov 2, 2026. From Jan 4, 2027, a TB-free certificate must be submitted with a Certificate of Eligibility or visa application.
Japan's Ministry of Health, Labour and Welfare is revising which diseases qualify as designated intractable diseases and the severity criteria for medical fee subsidies. Public comment runs to 29 October 2026 and applies to insured foreign residents too.
Japan's Ministry of Health, Labour and Welfare opened a public comment period on 7 September 2026 for a draft cabinet order arranging related orders for the partial enforcement of the Act amending the Social Welfare Act and others. Comments are accepted via e-Gov from 20:00 on 7 September until 20:00 on 7 October 2026, and anyone may submit regardless of nationality.